Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Palermo
Clinical trial register · Italy

Clinical Trials in Palermo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Palermo20 Janssen Research & Development, LLC13 Hoffmann-La Roche12 AbbVie12 AstraZeneca10
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Palermo

279 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Liver Steatosis in Pediatric CD Patients
NCT06206616Celiac Disease in Children, Non-Alcoholic Fatty Liver Disease
University of Palermo
Observational
91
Palermo
2027-11-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Florence, Palermo
2026-12-16
Not yet open
Non-Coding RNAs Gene Expression in Psychiatric Disorders
NCT07649993Schizophrenia Disorders, Major Depression, Bipolar Affective Disorders, Obsessive Compulsive Disorder (OCD)
Carmen Concerto
Observational
384
Catania, Enna, Messina, Palermo
2026-09-01
Not yet open
NEUROphysiology of CRACK Use Disorder in ITaly
NCT07735923Crack Cocaine Use
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Not applicable
104
Palermo
2026-09-01
Not yet open
Neurocognitive Assessment in Long-Term Survivors of Lymphoma
NCT07652476Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal B Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Ancona, Aviano, Bari, Legnano, Milan, Palermo
2026-09
Recruiting
AstraZeneca
Phase 3
2,500
Bologna, Milan, Palermo, Pisa, Roma, Rozzano, Sesto San Giovanni, Torino
2026-08-19
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
DrugsEtoposide·Atezolizumab·Carboplatin
SystImmune Inc.
Phase 3
550
Aviano, Palermo, Roma, Siena
2026-08-04
Recruiting
Boehringer Ingelheim
Phase 3
390
Bari, Florence, Milan, Naples, Palermo, Roma, Verona
2026-07-10
Recruiting
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490Liver Transplantation (LT), Ischemia-Reperfusion Injury, Early Allograft Dysfunction
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Not applicable
170
Ancona, Bari, Bergamo, Bologna, Genova, Modena, Padova, Palermo
2026-07-07
Not yet open
Inflammatory Back Pain and Gluten Free Diet
NCT03017716Inflammatory Back Pain
University of Palermo
Not applicable
50
Sciacca, Palermo
2026-07-01
Not yet open
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
NCT07674394Liver Transplantation (LT), Early Allograft Dysfunction, Primary Non-function, Ischemia-Reperfusion Injury
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Not applicable
150
Milan, Palermo, Roma
2026-07
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
Not yet open
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
NCT07463781Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Observational
100
Alessandria, Ancona, Brescia, Palermo, Reggio Calabria, Roma, Taranto, Udine
2026-05
Recruiting
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
52
Caserta, Catania, Cinisello Balsamo, Florence, Naples, Padova, Palermo, Roma
2026-04-30
Active, closed
Novo Nordisk A/S
Phase 3
606
Ferrara, Genoa, Pavia, Palermo, Padova, Verona, Bologna, Rozzano (MI)
2026-04-21
Recruiting
Novo Nordisk A/S
Phase 3
630
Bologna, Rome, Milan, Palermo
2026-04-13
Recruiting
NCWS or IBS/FD in Relatives of CD Patients
NCT07584473Non Celiac Wheat Sensitivity, IBS (Irritable Bowel Syndrome), Functional Dyspepsia, Celiac Disease
University of Palermo
Not applicable
600
Palermo
2026-04-01
Recruiting
Octapharma
Phase 4
28
Catanzaro, Palermo
2026-04
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
Sanofi
Observational
60
Ancona, Palermo, Verona
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NCT07479277Non-Small Cell Lung Cancer, Postoperative Air Leak, NSCLC
Fondazione del Piemonte per l'Oncologia
Not applicable
160
Candiolo, Bolzano, Florence, Milan, Palermo, Pisa
2026-02-27
Recruiting
Boehringer Ingelheim
Phase 3
286
Bari, Bologna, Milan, Palermo, Pavia, Varese
2026-02-16
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Bergamo, Bologna, Cuneo, Florence, Palermo, Pavia, Pescara, Roma
2026-02-08
Recruiting
Exciva GmbH
Phase 2/3
300
Rome, Tricase, Brescia, Milan, Palermo
2026-02-02
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07234461Mastectomy and Breast Reconstruction, Sexual Wellness
European Institute of Oncology
Not applicable
200
Bari, Bologna, Cesena, Forlì, Milan, Olbia, Padova, Palermo
2026-01-21
Recruiting
Novartis Pharmaceuticals
Observational
50
Alessandria, Avellino, Brescia, Florence, Genova, Milan, Palermo, Roma
2026-01-13
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Genova, Milan, Rozzano, Modena, Padova, Palermo, Naples, Roma
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Modena, Naples, Palermo, Pisa, Roma, Varese
2025-12-10
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,200
Bologna, Cagliari, Catanzaro, Florence, Milan, Palermo, Potenza, Roma
2025-12-09
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,260
Bari, Bologna, Catania, Ferrara, Milan, Novara, Palermo, Parma
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Milan, Naples, Palermo, Pavia, Roma, Rozzano
2025-12-03
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Not yet open
Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
NCT07267780Ovarian Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Vulvar Carcinoma
National Cancer Institute, Naples
Observational
130
Naples, Palermo
2025-12
Recruiting
Hoffmann-La Roche
Phase 3
250
Naples, Cona (Ferrara), Rome, Milan, Novara, Palermo
2025-11-27
Recruiting
TrueLok Elevate PMCF Study
NCT07079774Wound of Skin, Ulcers, Soft Tissue Defect
Orthofix s.r.l.
Observational
153
Acquaviva delle Fonti, Parma, Roma, Tivoli, Palermo
2025-11-24
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Active, closed
Novo Nordisk A/S
Phase 3
300
Rome, Palermo, Bologna, Milan
2025-11-05
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bergamo, Bologna, Florence, Milan, Naples, Padova, Palermo, Roma
2025-10-15
Not yet open
Instituto de Investigación Hospital Universitario La Paz
Observational
200
Palermo, Padova
2025-09-30
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 4
230
Bergamo, Palermo
2025-09-25
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Foggia, Milan, Naples, Padova, Palermo, Roma, Rozzano, Torino
2025-09-02
Recruiting
Sanofi
Phase 2
30
Milan, Merano, Palermo, Pisa
2025-09-02
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Palermo
2025-08-28
Recruiting
Sanofi
Phase 3
90
Florence, Genoa, Milan, Naples, Meldola, Novara, Palermo, Trieste
2025-08-18
Recruiting
Novo Nordisk A/S
Phase 4
586
Bari, Catanzaro, Naples, Rome, Milan, Messina, Palermo, Fermo
2025-08-15
Recruiting
Sanofi
Phase 3
192
Florence, Milan, Naples, Rome, Orbassano, Palermo, Verona
2025-08-12
By invitation
Rede Optimus Hospitalar SA
Not applicable
620
Palermo, Pisa, Catania, Mestre, Roma, Siena, Trieste
2025-08-08
Active, closed
GlaxoSmithKline
Phase 2
168
Milan, Palermo, Pavia, Siena
2025-08-06
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
2025-07-21
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
Active, closed
Immunovant Sciences GmbH
Phase 2
180
Catania, Milan, Palermo, Perugia, Rome
2025-06-30
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
Readmission and Dehydration Prevention in Patients With Elective Ileostomy
NCT06824623Ileostomy - Stoma, Colorectal Surgery, Dehydration
Multidisciplinary Italian Study group for STOmas (MISSTO)
Observational
300
Legnano, Milan, Monza, Palermo, Rovigo, Sesto San Giovanni, Bologna
2025-06-01
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
200
Candiolo, Florence, Milan, Padova, Palermo, Rome
2025-05-27
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Ancona, Bologna, Civitanova Marche, Milan, Pagani, Palermo, Perugia, Pescara
2025-05-05
Recruiting
ARNAS Civico Di Cristina Benfratelli Hospital
Not applicable
60
Palermo
2025-05-02
Recruiting
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
NCT06086132Cancer Related Cardiovascular Toxicity
University of Bologna
Observational
10,000
Bologna, Palermo
2025-05-01
By invitation
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
NCT07070284Severe Community-Acquired Pneumonia (sCAP), Elderly Infection, Community-Acquired Infections, Health Care Quality, Access, and Evaluation
Joan Sabater-Riera
Observational
500
Modena, Rome, Gavardo, Palermo, Pisa
2025-05-01
Not yet open
University of Palermo
Observational
100
Palermo
2025-05
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Meldola, Rozzano, Palermo, Alessandria, Milan, Naples, Reggio Emilia
2025-04-11
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Rozzano, Bologna, Brescia, Milan, Palermo, Roma
2025-04-09
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
144
Milan, Palermo, Pavia
2025-04-03
Recruiting
AbbVie
Observational
700
Milan, Naples, Turin, Rome, Bari, Palermo
2025-03-28
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Brescia, Bergamo, Milan, Naples, Novara, Padova, Palermo, Pergine Valsugana
2025-03-26
Active, closed
Amgen
Phase 3
1,105
Bologna, Chieti, Florence, Milan, Palermo
2025-03-17
Recruiting
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
NCT07214324Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS
Observational
60
Bologna, Catania, Palermo, Reggio Emilia
2025-03-17
Recruiting
University of Palermo
Observational
40
Palermo
2025-03-15
Active, closed
Amgen
Phase 3
3,853
Bologna, Chieti, Florence, Milan, Palermo, Pisa, Roma
2025-03-12
Active, closed
University of Palermo
Not applicable
100
Palermo
2025-03-10
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Bologna, Genova, Palermo, Pescara, Perugia, Ravenna, Roma, Torino
2025-02-27
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Milan, Padova, Palermo, Roma
2025-02-01
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Bologna, Cagliari, Florence, Milan, Naples, Padova, Palermo, Pavia
2025-01-28
Recruiting
Landiolol in Mitral Valve Surgery
NCT06793670Cardiac Failure, Low Cardiac Output Syndrome
DrugLandiolol
Università Vita-Salute San Raffaele
Phase 4
1,500
Alessandria, Torino, Catania, Florence, Foggia, Genova, Milan, Palermo
2025-01-28
Recruiting
Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia
NCT07168850Limb Dystonia, Idiopathic Dystonia, Medication-refractory Dystonia, Dystonia, Focal
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
34
Mestre, Messina, Milan, Palermo
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Monza, Rionero in Vulture, Palermo, Candiolo, Ancona, Brescia, Milan, Novara
2025-01-27
Recruiting
IRCCS Policlinico S. Donato
Not applicable
30,000
Milan, Ancona, Genova, Naples, Palermo, Pavia, Pozzilli, Rome
2025-01-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
400
Bergamo, Bologna, Genova, Milan, Padova, Palermo, Pavia, Roma
2025-01-10
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bari, Cona, Florence, Milan, Novara, Padova, Palermo, Perugia
2025-01-03
Recruiting
Dietary Approach to Mild-to-moderate Psoriasis
NCT05644782Psoriasis, Gluten Sensitivity
University of Palermo
Not applicable
82
Palermo
2025-01-01
Recruiting
Istituto Oncologico Veneto IRCCS
Not applicable
200
Bergamo, Bologna, Foggia, Padova, Palermo, Udine, Verona
2024-12-20
Recruiting
GlaxoSmithKline
Phase 3
520
Ancona, Catania, Meldola FC, Palermo, Pavia, Pisa, Roma
2024-12-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Palermo, Siena, Bologna
2024-12-12
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Brescia, Catania, Genova, Milan, Palermo, San Donato Milanese, Torino, Verona
2024-12-12
Active, closed
Incidence of Fragility Fractures and Osteoporosis Screening in Chronic Stroke Patients
NCT06804252Chronic Stroke, Osteoporosis, Fragility Fractures
University of Palermo
Observational
50
Palermo
2024-12-10
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Milan, Palermo, Perugia, Pisa, Roma, Rozzano, Udine
2024-12-04
Active, closed
Daiichi Sankyo
Phase 3
700
Bari, Brescia, Meldola, Milan, Novara, Palermo, Roma, Rome
2024-11-19
Active, closed
BeOne Medicines
Phase 2
94
Brescia, Florence, Modena, Palermo
2024-11-14
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Bologna, Foggia, Milan, Modena, Palermo, Rome, Rozzano, Torino
2024-11-12
Recruiting
University of Palermo
Not applicable
40
Palermo
2024-11-02
Not yet open
Ketogenic Diet in MASLD-related cACLD
NCT06537466Steatohepatitis, Nonalcoholic, Steatosis of Liver, Cirrhosis, Liver
University of Palermo
Not applicable
50
Palermo
2024-11
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
DrugMosliciguat
Pulmovant, Inc.
Phase 2
135
Genova, Pavia, Naples, Palermo, Roma
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Foggia, Monza, Palermo, Pavia, Roma, Sassari, Ivrea, Trieste
2024-10-24
Active, closed
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
NCT06553768Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
DrugMaralixibat
Mirum Pharmaceuticals, Inc.
Phase 3
90
Bergamo, Palermo, Rome
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bologna, Foggia, Milan, Modena, Novara, Palermo, Rome, Rozzano
2024-10-14
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Rome, Candiolo, Palermo, Bologna, Milan
2024-10-09
Recruiting
Novartis Pharmaceuticals
Phase 2
200
Ancona, Milan, Rozzano, Modena, Palermo, Pavia, Roma, Verona
2024-10-09
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Recruiting
Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus
NCT07100613Oral Lichen Planus, Oral Lichen Planus Related Stress, Oral Mucosal Disease, Oral Pain
DrugsResveratrol·Clobetasol
University of Palermo
Phase 2
45
Palermo
2024-09-04
Recruiting
University of Cagliari
Observational
80
Cagliari, Novedrate, Troina, Messina, Palermo
2024-08-08
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Bologna, Florence, Genova, Milan, Palermo, Roma, Orbassano
2024-07-31
Active, closed
Arrowhead Pharmaceuticals
Phase 3
446
Rozzano, Palermo, Bologna, Brescia, Milan, Roma
2024-07-22
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Milan, Rozzano, Rome, Messina, Palermo, Pavia, Pisa
2024-07-12
Recruiting
University of Bologna
Observational
120
Bologna, Catania, Milan, Padova, Palermo, Rome, Siena, Turin
2024-07-09
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Bologna, Milan, Orbassano, Padova, Palermo, Prato, Roma
2024-07-09
Recruiting
AstraZeneca
Phase 3
240
Ancona, Bari, Catania, Milan, Padova, Palermo, Pavia, Pisa
2024-06-20
Active, closed
Celgene
Phase 3
850
Ravenna, Rome, Palermo, Novara
2024-06-19
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Recruiting
PENTA Foundation
Not applicable
3,080
Ferrara, Modena, Palermo, Vicenza
2024-05-28
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Cefalù, Genova, Palermo, Roma, Tricase
2024-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Bergamo, Foggia, Milan, Novara, Palermo, Roma, Rome, Rozzano
2024-05-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bari, Bologna, Brescia, Catania, Meldola, Milan, Novara, Palermo
2024-05-21
Recruiting
Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
NCT06338891Familial Mediterranean Fever, Non-celiac Gluten Sensitivity
University of Palermo
Observational
60
Palermo
2024-05-01
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
NCT06071507Gastric Outlet Obstruction, Pancreatic Cancer
IRCCS San Raffaele
Observational
250
Milan, Palermo
2024-04-15
Active, closed
Takeda
Phase 2
213
Bologna, Milan, Palermo, Rome, Rozzano
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Bologna, Cagliari, Catanzaro, Milan, Negrar, Padova, Palermo, Roma
2024-03-27
Recruiting
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
NCT06321003Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorder, Oral Leukoplakia, Proliferative Verrucous Leukoplakia
University of Palermo
Observational
200
Palermo
2024-03-13
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Roma
2024-03-13
Recruiting
Takeda
Phase 2
268
Bologna, Milan, Palermo, Roma, Rome, Rozzano
2024-03-05
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna, Caserta, Catania, Ferrara, Florence, Milan, Novara, Palermo
2024-03-01
Active, closed
Fundación EPIC
Observational
501
Naples, Palermo
2024-02-26
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
Pfizer
Phase 3
492
Milan, Legnano, Turin, Palermo, Ancona, Florence, Pisa, Bologna
2024-02-08
Recruiting
Meyer Children's Hospital IRCCS
Observational
90
Florence, Roma, Foggia, Palermo
2024-02-07
Active, closed
Genmab
Phase 3
1,095
Rozzano, Candiolo, Bologna, Catania, Palermo, Reggio Emilia, Roma
2024-02-05
Recruiting
University of Palermo
Not applicable
68
Palermo
2024-02-01
Recruiting
Casa Sollievo della Sofferenza IRCCS
Phase 2
30
San Giovanni Rotondo, Novara, Padua, Palermo
2024-01-25
Active, closed
AbbVie
Phase 2/3
89
Rozzano, Milan, Naples, Rome, Bologna, Palermo, Roma
2024-01-11
Active, closed
RECORDATI GROUP
Phase 2
93
Bologna, Padova, Palermo, Rome
2024-01-04
Recruiting
Liver Steatosis and Fibrosis in Non-Celiac Wheat Sensitivity Patients: a Prospective Study
NCT07750535Metabolic Dysfunction-Associated Steatotic Liver Disease, Non Celiac Wheat Sensitivity, Irritable Bowel Syndrome, Functional Dyspepsia
University of Palermo
Observational
250
Palermo
2024-01-01
Recruiting
Insel Gruppe AG, University Hospital Bern
Observational
2,800
Naples, Palermo, Perugia, Reggio Emilia
2024-01-01
Recruiting
Janssen-Cilag Ltd.
Observational
900
Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo
2023-12-18
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Naples, Palermo, Bologna, Milan, Padova, Roma, Rozzano
2023-12-13
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Bologna, Careggi, Rozzano, Milan, Padova, Palermo, Prato, Roma
2023-12-01
Active, closed
argenx
Observational
413
Florence, Gussago, Messina, Novara, Orbassano, Palermo, Pavia, Pisa
2023-11-29
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Palermo, Parma, Roma, Rozzano
2023-10-12
Recruiting
Sanofi
Phase 3
180
Milan, Padua, Palermo, Pavia, Siena
2023-10-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Recruiting
Abbott Medical Devices
Observational
1,000
Brescia, Castel Volturno, Milan, Palermo, Roma, San Donato Milanese, Torino
2023-09-29
Active, closed
PharmaMar
Phase 3
469
Rozzano, Naples, Aviano, Bologna, Candiolo, Orbassano, Padova, Palermo
2023-09-21
Active, closed
AbbVie
Phase 2
130
Florence, Milan, Naples, Bologna, Palermo, Roma
2023-09-21
Active, closed
Hoffmann-La Roche
Phase 3
687
Tricase, Bologna, Rome, Genoa, Rozzano, Palermo, Verona
2023-09-14
Recruiting
Hoffmann-La Roche
Phase 3
230
Meldola, Rome, Milan, Monza, Novara, Palermo, Bagno a Ripoli, Verona
2023-09-08
Active, closed
Boehringer Ingelheim
Phase 2
268
Florence, Palermo, Pavia, Rozzano (MI), Verona
2023-09-08
Recruiting
Gilead Sciences
Phase 3
402
Ancona, Castellana Grotte, Milan, Modena, Monza, Padova, Palermo, Pisa
2023-09-07
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
AstraZeneca
Phase 3
142
Castelfranco Veneto, Foggia, Palermo, Pisa, Rozzano
2023-08-16
Active, closed
SGLT-2 Inhibitors in the Treatment of Ascites
NCT05999773Ascites Hepatic, Cirrhosis, Liver, Diabete Type 2
University of Palermo
Observational
40
Palermo
2023-07-15
Recruiting
Meyer Children's Hospital IRCCS
Not applicable
300
Florence, Naples, Palermo
2023-07-06
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Naples, Cona, Ferrara, Pavia, Catania, Palermo
2023-06-28
Active, closed
OncoC4, Inc.
Phase 3
630
Ancona, Bari, Bergamo, Catania, Milan, Monza, Naples, Palermo
2023-06-28
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, Rozzano, Palermo, Genova, Milan, Modena, Naples, Padova
2023-06-19
Active, closed
Alfasigma S.p.A.
Observational
509
Bari, Milan, Pisa, Negrar, Palermo, Rozzano, Torino
2023-06-12
By invitation
AbbVie
Phase 3
650
Milan, Palermo
2023-06-05
Recruiting
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT06708429Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II, Lynch Syndrome I (Site-specific Colonic Cancer)
San Raffaele University
Observational
300
Milan, Palermo, Cagliari
2023-06-01
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
300
Palermo, Perugia
2023-05-31
Active, closed
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
NCT05831176Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID), Eosinophilic Gastroenteritis
DrugDupilumab
Regeneron Pharmaceuticals
Phase 2
22
Rozzano, Palermo, Bari, Milan, Pisa, Roma, Rome
2023-05-03
Active, closed
University of Palermo
Observational
40
Palermo
2023-05-01
Recruiting
AbbVie
Phase 3
450
Milan, Rome, Palermo
2023-05-01
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Cona, Foggia, Milan, Legnano, Palermo, Roma, Sassari, Trento
2023-04-30
Active, closed
Umecrine Cognition AB
Phase 1/2
84
Milan, Padova, Palermo, Roma, Rozzano, Udine
2023-04-14
Active, closed
Alfasigma S.p.A.
Phase 3
495
Bologna, Naples, Palermo, Rome, Udine
2023-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Bologna, Milan, Palermo, Pisa, Reggio Emilia, Roma, Siena, Turin
2023-03-29
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Trieste, Monza, Palermo
2023-03-16
Active, closed
Insmed Incorporated
Phase 2/3
91
Pavia, Monza, Palermo, Roma
2023-03-07
Recruiting
Takeda
Phase 3
160
Milan, Palermo, Pavia, Rozzano
2023-03-06
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Florence, Milan, Modena, Padova, Palermo, Roma, Rozzano MI, San Giovanni Rotondo FG
2023-01-02
Active, closed
Ipsen
Phase 2
68
Modena, Padova, Palermo, Rozzano, San Giovanni Rotondo
2022-12-29
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Battipaglia, Naples, Ferrara, Pavia, Catania, Palermo
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Catania, Milan, Naples, Padova, Palermo, Roma
2022-12-28
Active, closed
Sanofi
Phase 2
187
Bolzano, Milan, Rozzano, Rome, Catanzaro, Palermo, Pavia
2022-11-25
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Recruiting
Pfizer
Phase 3
1,060
Meldola (Fc), Piacenza, Ravenna, San Giovanni Rotondo, Aviano, Monza, Turin, Palermo
2022-11-10
Active, closed
University of Bologna
Observational
240
Padova, Palermo, Varese, Verona
2022-11-01
Recruiting
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Phase 3
72
Palermo
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Ancona, Bari, Bologna, Brescia, Catania, Milan, Padova, Palermo
2022-10-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bari, Bologna, Como, Ferrara, Florence, Latina, Padova, Palermo
2022-10-11
Active, closed
Hoffmann-La Roche
Phase 3
122
Naples, Genoa, Milan, Pavia, Palermo
2022-09-27
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bari, Catania, Messina, Milan, Monserrato, Monza, Negrar, Palermo
2022-09-19
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
San Giovanni Rotondo, Milan, Rozzano, Roma, Torino, Florence, Palermo, Pisa
2022-08-26
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Milan, Naples, Novara, Palermo, Rozzano
2022-08-03
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome, Milan, Palermo, Florence, Alessandria
2022-07-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
154
Catania, Naples, Padova, Palermo, San Donato Milanese
2022-07-13
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Ancona, Aviano, Florence, Miano, Monza, Naples, Roma, Palermo
2022-07-11
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Recruiting
BioMarin Pharmaceutical
Observational
450
Bologna, Florence, Milan, Naples, Padova, Palermo, Rome
2022-06-06
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
Recruiting
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT05487612Coronary Artery Disease, Aortic Valve Stenosis, Extracorporeal Circulation; Complications
Aristotle University Of Thessaloniki
Not applicable
1,300
Bari, Palermo
2022-05-26
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Aviano, Bologna, Brescia, Candiolo, Florence, Meldola, Milan, Palermo
2022-04-14
Active, closed
Sanofi
Phase 3
122
Bologna, Monza, Naples, Palermo, Roma
2022-03-11
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2/3
286
Naples, Modena, Rome, Genoa, Palermo
2022-02-11
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Ferrara, Milan, Naples, Palermo, Pavia, Rozzano, Terni
2022-02-07
Recruiting
Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor Surgery
NCT07717827Brain (Nervous System) Cancers, Glioma, Brain Metastasases, Brain Connectivity
ARNAS Civico Di Cristina Benfratelli Hospital
Observational
400
Palermo
2022-01-01
Recruiting
Xingshun Qi
Observational
3,000
Palermo
2022-01-01
Active, closed
Società Italiana Talassemie ed Emoglobinopatie
Observational
1,000
Torino, Cagliari, Ferrara, Genova, Milan, Naples, Palermo, Roma
2022-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Bari, Bergamo, Bologna, Florence, Genova, Milan, Rozzano, Palermo
2021-12-17
Active, closed
GlaxoSmithKline
Phase 2
360
Bergamo, Milan, Modena, Naples, Palermo, Pisa
2021-12-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
60
Naples, Palermo, Rome
2021-11-18
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Aversa, Brescia, Genova, La Spezia, Milan, Paderno Dugnano, Palermo, Roma
2021-11-16
Active, closed
Hoffmann-La Roche
Phase 3
478
Bologna, Ravenna, Palermo, Ancona, Florence, Padova
2021-10-27
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bologna, Candiolo, Milan, Palermo, Prato, Roma
2021-09-23
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Ancona, Bergamo, Milan, Modena, Monza, Padova, Palermo, Pisa
2021-09-22
Recruiting
Italian Sarcoma Group
Phase 2
16
Prato, Roma, Candiolo, Bologna, Milan, Palermo
2021-09-14
Recruiting
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Not applicable
78
Arezzo, Florence, Genova, Milan, Palermo, Perugia, Pistoia
2021-09-14
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
Active, closed
Inventiva Pharma
Phase 3
1,000
San Giovanni Rotondo, Milan, Naples, Palermo, Roma, Bologna, Novara, Torino
2021-08-19
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bergamo, Brescia, Florence, Genova, Milan, Palermo, Torino, Trieste
2021-07-13
Recruiting
Corcym S.r.l
Observational
2,150
Ancona, Bologna, Brescia, Lecce, Massa, Milan, Naples, Palermo
2021-06-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Catania, Milan, Naples, Palermo, Rome, Torino, Verona
2021-06-17
Active, closed
University Hospital of Ferrara
Not applicable
249
Ferrara, Bologna, Forlì, Palermo, Ravenna, Rimini, Trieste
2021-06-03
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, San Giovanni Rotondo, Bari, Cagliari, Novara, Palermo, Reggio Emilia, Terni
2021-05-20
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Alessandria, Meldola, Ravenna, Milan, Bologna, Genova, Palermo, Potenza
2021-04-08
Recruiting
Italian Sarcoma Group
Observational
300
Bologna, Milan, Rozzano, Palermo, Aviano, Prato, Roma, Candiolo
2021-04-02
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Recruiting
Centro Cardiologico Monzino
Observational
10,000
Milan, Ancona, Bari, Bergamo, Brescia, Foggia, Naples, Palermo
2021-02-10
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Pavia, Catania, Orbassano, Padova, Palermo, Roma
2021-01-29
Recruiting
University of Palermo
Not applicable
40
Palermo
2021-01-01
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Observational
496
Alessandria, Ponderano, Cagliari, Catania, Milan, Palermo, Padova, Pescara
2020-12-01
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Milan, Naples, Palermo, Roma
2020-11-23
Active, closed
Hoffmann-La Roche
Phase 3
985
Naples, Parma, Rome, Genoa, Milan, Montichiari, Pozzilli, Palermo
2020-10-26
Active, closed
AbbVie
Phase 3
527
Bologna, Genoa, Milan, Rho, Rome, Negrar, Cagliari, Palermo
2020-09-30
Active, closed
University of Zurich
Not applicable
986
Cuneo, Genova, Palermo, Turin
2020-09-30
Active, closed
Ipsen
Phase 3
161
Modena, Bologna, Milan, Monza, Padova, Palermo
2020-09-24
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Active, closed
Bristol-Myers Squibb
Phase 3
790
Palermo, Bergamo, Milan, Naples, Padova, Perugia, Siena
2019-10-28
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Bologna, Milan, Negrar, Padova, Palermo, Rho, Roma, Rozzano
2019-09-26
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Palermo, Foggia, Genova, Milan, Monza, Pavia, Roma
2019-09-23
Active, closed
LITMUS Imaging Study
NCT05479721NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
University of Oxford
Observational
450
Palermo, Torino
2019-09-04
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Amgen
Phase 3
457
Milan, Palermo, Pavia, Roma
2019-07-19
Recruiting
Population Health Research Institute
Phase 4
2,270
Milan, Alessandria, Palermo, Piacenza
2019-06-14
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
Recruiting
Hospices Civils de Lyon
Observational
3,500
Milan, Palermo, Parma
2019-02-25
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bologna, Meldola, Milan, Padova, Palermo, Rome
2019-02-08
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Ancona, Bergamo, Bologna, Misterbianco, Milan, Rozzano, Palermo, Aviano
2018-12-07
Active, closed
AbbVie
Phase 3
265
Bologna, Turin, Rionero in Vulture, Ancona, Milan, Palermo, Terni
2018-10-22
Recruiting
Associazione Angela Serra per la ricerca sul cancro
Observational
1,000
Bari, Palermo, Terni
2018-10-14
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Bergamo, Naples, Palermo
2018-04-26
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Active, closed
Gilead Sciences
Phase 3
340
Modena, Palermo, Rozzano
2017-12-12
Recruiting
An Observational Study on Epithelioid Sarcoma
NCT03099681Epithelioid Sarcoma
Italian Sarcoma Group
Observational
100
Meldola, Milan, Rozzano, Palermo, Candiolo, Bologna, Padova, Prato
2017-08-22
Recruiting
Advenchen Laboratories, LLC
Phase 3
325
Milan, Palermo, Rome
2017-08-15
Active, closed
Acerta Pharma BV
Phase 3
635
Bologna, Milan, Palermo, Parma, Pavia, Reggio Emilia, Rozzano, Turin
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
Bergamo, Meldola, Milan, Palermo, Roma, Terni
2017-03-27
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Milan, Palermo, Pordenone, Ravenna, Reggio Emilia, Roma, Terni
2017-03-07
Active, closed
AbbVie
Phase 3
950
Bologna, Rozzano, Milan, Rho, Rome, Negrar, Palermo
2017-01-31
Recruiting
University of Palermo
Not applicable
50
Sciacca, Palermo
2017-01-01
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Milan, Palermo, Rozzano, San Giovanni Rotondo
2016-12
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Bari, Cuneo, Genova, Milan, Palermo, Rome, Torino, Udine
2016-12
Recruiting
Observational Study on Endometrial Stromal Tumors
NCT02829437Endometrial Stromal Tumors
Italian Sarcoma Group
Observational
100
Meldola, Milan, Palermo, Aviano, Padova, Candiolo, Bologna, Florence
2016-10
Recruiting
UMC Utrecht
Phase 3
20,000
Brescia, Milan, Palermo, Reggio Emilia, Rimini
2016-04-11
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Ancona, Milan, Palermo, Rome, Turin
2015-05-01
Active, closed
Acerta Pharma BV
Phase 1/2
113
Bologna, Milan, Palermo
2014-12-29
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Active, closed
San Rocco Therapeutics
Phase 1
10
Palermo
2012-07
Recruiting
Bio-markers of Not-celiac Wheat Sensitivity
NCT01762579Not-celiac Wheat Sensitivity
University of Palermo
Not applicable
100
Sciacca, Palermo
2012-01-01
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
1,000
Milan, Palermo, Parma, Urbino, Bologna, Carrara, Genova, Naples
2010-09
Rows per page Showing 1–279 of 279
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/palermo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 279 of those studies with a site in Palermo.

How many clinical trials are recruiting in Palermo?

139 of the 279 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 11 have not yet opened recruitment, 122 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Palermo), 279 studies
PhaseStudiesRecruitingShare
Phase 31164541.6%
Observational734726.2%
Phase 2371313.3%
Not applicable322311.5%
Phase 2/31043.6%
Phase 4652.2%
Phase 1/2421.4%
Phase 1100.4%

Most active sponsors

Lead sponsors with the most studies (Palermo)
Lead sponsorStudiesRecruiting
University of Palermo2013
Janssen Research & Development, LLC134
AbbVie122
Hoffmann-La Roche125
AstraZeneca106
Sanofi85
Eli Lilly and Company73
GlaxoSmithKline72
IRCCS Azienda Ospedaliero-Universitaria di Bologna75
Merck Sharp & Dohme LLC62
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.